STAND. COM. REP. NO. 506-20
RE: H.B. No. 2633
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirtieth State Legislature
Regular Session of 2020
State of Hawaii
Your Committees on Consumer Protection & Commerce and Judiciary, to which was referred H.B. No. 2633, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO CANNABIS FOR MEDICAL USE,"
beg leave to report as follows:
The purpose of this measure is to amend the State's medical cannabis dispensary system law to:
(1) Exclude propagules and cuttings from certain dispensing limits; and
(2) Limit the amount of propagules and cuttings that a qualified patient and primary caregiver may purchase during a certain number of consecutive days.
Your Committees received testimony in support of this measure from Kush Hawaii, Big Island Grown, Maui Grown Therapies, Patients Without Time, and two individuals. Your Committees received testimony in opposition to this measure from the Department of Health.
Your Committees find that patients and primary caregivers cultivating medical cannabis at a registered grow site under the State's medical cannabis registry program have no legal means of obtaining safe, laboratory-tested genetic material from which to propagate their plants. In other words, patients have no means to legally buy the material to grow cannabis. Existing law often requires patients or their primary caregivers to obtain propagules, cuttings, or other cannabis genetic material from the illicit market. Amending the State's medical cannabis dispensary system law will allow qualifying patients to access safe and quality-assured medical cannabis and medical cannabis products.
Your Committees have amended this measure by making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the records of votes of the members of your Committees on Consumer Protection & Commerce and Judiciary that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 2633, H.D. 1, as amended herein, and recommend that it be referred to your Committee on Finance, in the form attached hereto as H.B. No. 2633, H.D. 2.
Respectfully submitted on behalf of the members of the Committees on Consumer Protection & Commerce and Judiciary,
CHRIS LEE, Chair
ROY M. TAKUMI, Chair